Skip to content

TBI-Prognosis Multicenter Prospective Study

Early Determination of Neurological Prognosis in ICU Patients With Severe Traumatic Brain Injury: The TBI-Prognosis Multicenter Prospective Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02452541
Enrollment
315
Registered
2015-05-22
Start date
2013-04-30
Completion date
2017-09-30
Last updated
2016-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Brain Injury

Keywords

Traumatic Brain Injury, Critically ill Patients, Death, Head Injury, TBI-Prognosis, Critical Care Medicine, Withdrawal of Life Sustaining Therapy, Prognosis, Prognostic Evaluation, Outcome Research, Mortality, Decision-making

Brief summary

Severe traumatic brain injury (TBI) is the leading cause of death and disability among people under 45 years of age and a major public health problem. Although management of severe TBI patients has gradually improved with the establishment of intensive care units (ICU) and the development of practice guidelines, mortality is still high - ranging from 30 to 50% - with 30% of survivors suffering from severe neurological sequelae such as neurovegetative states. Families and medical teams are frequently called upon to determine reasonable and appropriate goals of care for brain injured patients. They may have to consider high intensity of care, but also the withdrawal of life-sustaining therapies in accordance with patient wishes. Physicians involved in the care of severe traumatic brain injury have expressed serious concerns about hasty decisions made in the absence of appropriate evidence of unfavourable prognosis. The purpose of the TBI-Prognosis study is to develop a prognostic model by using a multimodal approach of different prognostic indicators and their evolution over time in the acute phase of care. The results of this study will provide better objective information that will facilitate the shared-decision making-process with families and relatives.

Interventions

OTHERPrognostic tests

* Brain CT-Scan on day 1, 3 and 7 * Brain MRI on day 7 * SomatoSensory Evoked Potentials on day 7 * Electroencephalogram on day 7 * Serum biomarkers on day 1, 3 and 7 * Daily clinical exams

Sponsors

Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
Fonds de la Recherche en Santé du Québec
CollaboratorOTHER_GOV
Canadian Critical Care Trials Group
CollaboratorOTHER
CHU de Quebec-Universite Laval
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults (≥ 18 years) with severe blunt TBI admitted to the ICU * All patients with a GCS ≤ 8 after initial resuscitation

Exclusion criteria

* Anticipated being on mechanical ventilation for \< 48 hour period due to an altered level of consciousness related to the TBI plus another potentially reversible factor (i.e. drugs, substance abuse, excessive sedation, etc.). * Solid malignancy with a life expectation \<12 months * Liver cirrhosis Child C * Chronic heart failure (NYHA class IV) * End-stage chronic respiratory disease (O2 dependent) * End-stage renal disease (initiated or expectant chronic dialysis or to be expected) * Previous neurologic disorder with abnormal findings (such as a mass lesion) on radiological imaging (CT-scan, MRI) or electrophysiological tests (EEG, SSEP) (such as previous uncontrolled epilepsy, significant stroke, previous or acute concomitant spinal cord injury, etc) * Patients with no fixed address will be excluded because of the difficult follow-up * Physician refusal

Design outcomes

Primary

MeasureTime frame
Glasgow Outcome Scale Extended12 months

Secondary

MeasureTime frame
EuroQuol - EQ-5D-5L12 months
Glasgow Outcome Scale Extended6 months

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026